Federal appeals court blocks mailing of abortion pills in ruling with nationwide effect

A federal appeals court blocked the mailing of the abortion pill mifepristone under current FDA rules, requiring in-person prescriptions and likely sparking a Supreme Court battle. The 5th U.S. Circuit Court of Appeals decision restores pre-pandemic safety protocols, citing concerns over adverse event reporting and state authority, while critics warn it will limit abortion access nationwide.